Description

1-(p-Chlorophenyl)-1,4-Dihydro-4-Methyl-3-(3-Morpholinopropylaminocarbonyl)Pyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide is a high-purity, complex heterocyclic organic compound with significant pharmaceutical research and development value. This compound serves as a critical advanced intermediate or active pharmaceutical ingredient (API) building block in the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new drug candidates, particularly in areas requiring specialized benzothiazine derivatives.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel drug candidates targeting inflammation, CNS disorders, or other therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes in drug discovery.
• Reference Standard: Serves as a high-purity analytical standard for method development and quality control in API manufacturing.
• Biochemical Research: Potential tool compound for investigating specific enzymatic pathways or biological mechanisms in preclinical studies.
• Custom Synthesis: Starting material for the contract manufacturing of specialized, non-commercial APIs for clinical trials.

Basic Information

Product Name	1-(p-Chlorophenyl)-1,4-Dihydro-4-Methyl-3-(3-Morpholinopropylaminocarbonyl)Pyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide
CAS No.	81761-97-9
Molecular Formula	C24H25ClN4O4S
Molecular Weight	501.00 g/mol
Synonyms	1-(4-Chlorophenyl)-1,4-dihydro-4-methyl-3-[[3-(4-morpholinyl)propyl]carbamoyl]pyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide; 81761-97-9; UNII-8V3Y9Q8W4F; 8V3Y9Q8W4F; Pyrazolo[4,3-c][1,2]benzothiazine-3-carboxamide, 1-(4-chlorophenyl)-1,4-dihydro-4-methyl-N-[3-(4-morpholinyl)propyl]-5,5-dioxide-; SCHEMBL23545427; DTXSID40422319
EINECS	Contact for details

Quality Control

Our 1-(p-Chlorophenyl)-1,4-Dihydro-4-Methyl-3-(3-Morpholinopropylaminocarbonyl)Pyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing all specifications and test results is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.